Dr John Bridgewater, Consultant Medical Oncologist
Dr John Bridgewater
Consultant Medical Oncologist
Dr Bridgewater is a recommended Consultant Medical Oncologist
Areas of expertise
- Gastrointestinal oncology
- Biliary cancer
- Colorectal/bowel cancer
- Cancer of unknown primary
- Liver cancer
Recommendations for Dr Bridgewater
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
HCA UK at University College Hospital
Grafton Way Building, 1 Grafton Way, London, WC1E 6AG
-
LOC - Leaders in Oncology Care
95-97 Harley Street, London, W1G 6AF
About Dr John Bridgewater
GMC number: 3168013
Year qualified: 1986
Place of primary qualification: University of London
Areas of expertise
- Cancer unknown primary
- Gastrointestinal cancer
- Testis cancer
- Colorectal cancer
- Oesophagogastric cancer
- Hepatobillary cancer
- Biliary tract cancers
Professional memberships
Articles by Dr John Bridgewater
Diagnostic accuracy for metastatic disease in newly diagnosed non-small cell lung cancer: prospective comparison of whole-body magnetic resonance imaging with standard staging pathways-the streamline l trial
Diagnostic accuracy for metastatic disease in newly diagnosed colorectal cancer: prospective comparison of whole-body magnetic resonance imaging with standard staging pathways - the “streamline c” trial
Diagnostic accuracy of whole-body mri versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective streamline l trial
Covid-19 in cancer patients on systemic anti-cancer therapies: outcomes from the capitol (covid-19 cancer patient outcomes in north london) cohort study
Lba83 outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre north london experience
Patient preferences for whole-body mri or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment
P-70 multimodal treatment in metastatic colorectal cancer improves outcomes: a university college london hospital experience
Patient deprivation and perceived scan burden negatively impact the quality of whole-body mri
